Is Eagle Pharmaceuticals, Inc. (EGRX) a Buy, Sell, or Hold?
OTC : EGRX
Eagle Pharmaceuticals, Inc. — News
$0.06885 USD
$0.02 (35.27%)
- Volume
- 837
- Average Volume
- 3.88K
- Market Capitalization
- $905.9K
- P/E Ratio
- 0.02
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.87
- Year Low
- $0.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.70
| Source | Headline |
|---|---|
|
Galera Therapeutics (NASDAQ:GRTX) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Review
Profitability This table compares Galera Therapeutics and Eagle Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Galera Therapeutics N/A N/A -99.34% Eagle Pharmaceuticals N/A N/A N/A Earnings and Valuation This table compares Galera Therapeutics and Eagle Pharmaceuticals"s top-line revenue, earnings per share and valuation. Gross defenseworld.net - 2026-07-17 04:23:27 |
